Pure-play API manufacturer supplying 60+ pharma ingredients to 70+ countries from 6 Indian plants.
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 27 | 36 | 36 | 36 | 36 | 40 | 44 | 45 |
| Reserves | 1.1k | 1.6k | 1.5k | 1.5k | 898 | 1.1k | 1.2k | 1.2k |
| Borrowings | 722 | 621 | 1.0k | 1.0k | 1.0k | 796 | 646 | 687 |
| Other Liabilities | 346 | 404 | 383 | 386 | 406 | 342 | 393 | 393 |
| Total Liabilities | 2.2k | 2.6k | 2.9k | 2.9k | 2.4k | 2.2k | 2.3k | 2.3k |
| AssetsFixed Assets | 1.4k | 1.4k | 1.4k | 1.4k | 1.3k | 1.2k | 1.2k | 1.2k |
| CWIP | 40 | 88 | 239 | 238 | 256 | 280 | 230 | 205 |
| Investments | 0 | 0 | 0 | 2 | 2 | 2 | 2 | 5 |
| Other Assets | 716 | 1.1k | 1.4k | 1.3k | 825 | 757 | 829 | 886 |
| Total Assets | 2.2k | 2.6k | 2.9k | 2.9k | 2.4k | 2.2k | 2.3k | 2.3k |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 166 | 242 | 155 | -242 | 156 | 109 | 213 | 153 |
| Cash from Investing | -113 | -359 | -106 | -243 | -81 | -4 | -37 | -99 |
| Cash from Financing | -23 | 97 | 92 | 334 | -113 | -106 | -180 | -54 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | 108 | -25 | -16 | -451 | 46 | 69 | 173 | 101 |
| FCF Margin | — | — | — | — | — | — | — | — |
This looks cyclical, and we don't have enough quarters to establish a through-cycle earnings base. Valuing it off the current point in the cycle would be misleading.
SOLARA · CYCLICAL_UNMODELABLE
Guides on how to read this kind of business and the numbers that matter.